#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine carcinoma of the skin Infantile apnoea Acute graft versus host disease Acute promyelocytic leukaemia Anti-neutrophil cytoplasmic antibody positive vasculitis Ovarian cancer Synovitis Pyruvate kinase deficiency anaemia Osteosarcoma Follicular lymphoma stage I Malignant melanoma Aspergillus infection Congenital ectodermal dysplasia Obliterative bronchiolitis Synovial sarcoma metastatic More trials…

    Learn about Rare Diseases

    Optic glioma – Treatment Mastocytosis – Treatment Hereditary neuropathic amyloidosis – Trials in Disease Osteosarcoma metastatic Osteosarcoma recurrent – Treatment VEXAS syndrome Hepatic angiosarcoma – Life with Disease Marfan’s syndrome – Basic Information Nephroblastoma Haemophilia A without inhibitors More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Capmatinib Resomelagon Valemetostat Tosilate Radotinib Dihydrochloride AZD3632 Ampreloxetine Larotrectinib Sulfate BENZYDAMINE HYDROCHLORIDE MARALIXIBAT Dextran 70 Bendamustine Hydrochloride GSKVX000000034794 Digitoxin Sulfamethoxazole Zinc Acetate Dihydrate Rtx001 Teicoplanin Tanimilast SRSD107 Mk-6194 More therapies…

    Learn about Your Condition

    Biliary cancer metastatic Small cell lung cancer Open angle glaucoma Hyperglycaemia Haemorrhage intracranial Choroidal dystrophy Pulmonary sarcoidosis Foetal growth restriction Metastases to biliary tract Tuberculosis Metastatic glioma Nephrogenic anaemia Muscle injury Becker's muscular dystrophy Fontan procedure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Azetukalner in Patients with Focal-Onset Seizures

    Recruiting

    3 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Azetukalner
    Austria Belgium Bulgaria Croatia Czechia Finland +8

  • Study on Hydroxychloroquine for Improving Pregnancy Outcomes in Women with Antiphospholipid Antibodies

    Recruiting

    3 1 1
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    Denmark Ireland Italy

  • Study on the Effects of Rituximab for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    2 1 1
    Investigated Drugs:
    • Methylprednisolone Hydrogen Succinate
    • Paracetamol
    • Rituximab
    Germany

  • Study on the Safety and Effects of UX701 Gene Therapy for Adults with Wilson Disease

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 9 Encoding Human Atp7B
    • Prednisolone
    • Eculizumab
    Denmark France Germany Italy Portugal Spain

  • Study on Pain in Parkinson’s Disease: Examining the Effects of 18F-MPPF in Patients with and without Pain

    Recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • 4-Fluoro-N-[2-[4-(2-Methoxyphenyl)Piperazin-1-Yl]Ethyl]-N-Pyridin-2-Ylbenzamide
    France

  • Study on the Safety and Effectiveness of TransCon CNP for Children and Adolescents with Achondroplasia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Austria Denmark Finland France Germany Ireland +4
Previous Page
1 … 586 587 588 589 590 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!